Osaic Holdings
LABU icon

Osaic Holdings’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Osaic Holdings’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$166 – 8097
2026
Q1 		$166 Buy
+1
New +$164 ﹤0.01% 7585
2025
Q2 		– Sell
-5
Closed -$305 – 7818
2025
Q1 		$305 Buy
+5
New +$426 ﹤0.01% 7097
2022
Q4 		– Sell
-85
Closed -$12K – 7324
2022
Q3 		$12K Sell
85
-170
-67% -$31.2K ﹤0.01% 5916
2022
Q2 		$34K Buy
255
+95
+59% +$16.2K ﹤0.01% 5235
2022
Q1 		$50K Buy
160
+63
+65% +$23.8K ﹤0.01% 5089
2021
Q4 		$70K Buy
97
+17
+21% +$16.3K ﹤0.01% 4887
2021
Q3 		$88K Buy
80
+72
+900% +$88.5K ﹤0.01% 4642
2021
Q2 		$11K Buy
+8
New +$11.1K ﹤0.01% 6001
2020
Q3 		– Sell
-5
Closed -$6K – 6317
2020
Q2 		$6K Buy
+5
New +$4.34K ﹤0.01% 5402

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return

Osaic Holdings's LABU Position: Q2 2026 in Review

Osaic Holdings sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2026, closing a stake of 1 share — an estimated $166 sold.

Osaic Holdings first reported a position in LABU in Q2 2020 and held it in 9 quarters. The position peaked at $88K in Q3 2021. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Osaic Holdings reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2026 after selling out during the quarter.
  • Osaic Holdings sold 1 Direxion Daily S&P Biotech Bull 3X ETF share in Q2 2026, an estimated $166.
  • Osaic Holdings first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2020 and held it in 9 quarters.
  • Osaic Holdings's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $88K in Q3 2021.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.